Synthes, Inc. Confirms in Deal Talks with Johnson & Johnson for Potential $20 Billion Deal

ZURICH (Reuters) - Synthes said on Monday it was in takeover talks with Johnson & Johnson after reports the U.S. group is looking to buy the Swiss medical device maker for about $20 billion.

MORE ON THIS TOPIC